Boundless Bio, Inc. (BOLD)
NASDAQ: BOLD · Real-Time Price · USD
1.150
-0.020 (-1.71%)
Aug 14, 2025, 1:56 PM - Market open
Boundless Bio Market Cap
Boundless Bio has a market cap or net worth of $25.74 million as of August 14, 2025. Its market cap has decreased by -70.03% in one year.
Market Cap
25.74M
Enterprise Value
-51.45M
1-Year Change
-70.03%
Ranking
Category
Stock Price
$1.15
Market Cap Chart
Since the IPO on March 28, 2024, Boundless Bio's market cap has decreased from $355.83M to $25.74M, a decrease of -92.77%. That is a compound annual growth rate of -85.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 26.19M | -59.50% |
| Dec 31, 2024 | 64.67M | -81.83% |
| Mar 28, 2024 | 355.83M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 592.95B |
| Johnson & Johnson | 420.06B |
| AbbVie | 355.91B |
| UnitedHealth Group | 246.17B |
| AstraZeneca | 240.81B |
| Novartis AG | 234.72B |
| Novo Nordisk | 227.37B |
| Abbott Laboratories | 225.22B |